Sea anemone peptide ShK treats multiple sclerosis in rats - PowerPoint PPT Presentation

1 / 3

About This Presentation

Title:

Sea anemone peptide ShK treats multiple sclerosis in rats

Description:

Sea anemone peptide (ShK) treats multiple sclerosis in rats. Saline day-5. Saline day-6 am ... Saline-treated rats. ShK day-5. ShK day-6 am. ShK day-6 pm. ShK ... – PowerPoint PPT presentation

Number of Views:52

Avg rating:3.0/5.0

Slides: 4

Provided by: gag8

Category:

Tags: shk | anemone | multiple | peptide | rats | sclerosis | sea | treats

Transcript and Presenter's Notes

Title: Sea anemone peptide ShK treats multiple sclerosis in rats

1
Sea anemone peptide (ShK) treats multiple
sclerosis in rats
2
Saline-treated rats
3
ShK-treated rats
ShK day-5

Write a Comment

User Comments (0)

About PowerShow.com

Recommended Relevance Latest Highest Rated Most Viewed

Sort by:

Related More from user

CrystalGraphics Presentations

Introducing-PowerShowcom PowerPoint PPT Presentation

Introducing-PowerShowcom - Introducing-PowerShowcom (Without Music)

CrystalGraphics 3D Character Slides for PowerPoint PowerPoint PPT Presentation

CrystalGraphics 3D Character Slides for PowerPoint - CrystalGraphics 3D Character Slides for PowerPoint

Chart and Diagram Slides for PowerPoint PowerPoint PPT Presentation

Chart and Diagram Slides for PowerPoint - Beautifully designed chart and diagram s for PowerPoint with visually stunning graphics and animation effects. Our new CrystalGraphics Chart and Diagram Slides for PowerPoint is a collection of over 1000 impressively designed data-driven chart and editable diagram s guaranteed to impress any audience. They are all artistically enhanced with visually stunning color, shadow and lighting effects. Many of them are also animated. And they’re ready for you to use in your PowerPoint presentations the moment you need them. – PowerPoint PPT presentation

Related Presentations

Esperanza Peptide Ltd. PowerPoint PPT Presentation

Esperanza Peptide Ltd. - ... drug for any form of Multiple Sclerosis. a-Immunokine-NNS. Snake Oil or ... Multiple Sclerosis is the primary focus of our current R&D and our MS product is ... | PowerPoint PPT presentation | free to view

Adaptations to High Current in the Giant Green Anemone Anthopleura xanthogrammica PowerPoint PPT Presentation

Adaptations to High Current in the Giant Green Anemone Anthopleura xanthogrammica - Sea Anemones are Carnivores ... We might expect sea anemones to tilt crown (prey catching surface) towards oncoming water flow ... | PowerPoint PPT presentation | free to view

US Multiple Sclerosis Market 2015 - Size, Share, Growth & Forecast 2019 PowerPoint PPT Presentation

US Multiple Sclerosis Market 2015 - Size, Share, Growth & Forecast 2019 - Big Market Research “Multiple Sclerosis Market in the US” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/multiple-sclerosis-in-the-us-2015-2019-market Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. | PowerPoint PPT presentation | free to view

Key Factors Relapsing Remitting Multiple Sclerosis (RRMS) Market 2016 PowerPoint PPT Presentation

Key Factors Relapsing Remitting Multiple Sclerosis (RRMS) Market 2016 - Download Sample Brochure @ http://tinyurl.com/j8ycq9o Marketintelreports, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS) and features dormant and discontinued projects. | PowerPoint PPT presentation | free to view

Strategic Analysis on Global Primary Progressive Multiple Sclerosis Market, 2016 PowerPoint PPT Presentation

Strategic Analysis on Global Primary Progressive Multiple Sclerosis Market, 2016 - Avail more information from Sample Brochure of report @ http://bit.ly/2o6an7B A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Global Primary Progressive Multiple Sclerosis Market and future opportunities are provided in the report. | PowerPoint PPT presentation | free to view

Methods Of Rat Control Services Provider PowerPoint PPT Presentation

Methods Of Rat Control Services Provider - Rodents such as mice and rats are not only capable of causing damage to property, but are known to cause diseases, that's why the immediate solution of the rats must be done. You can take the consultation of the rat control services provider. Contact Atlanta Rat Removal for best solutions: www.atlantaratremoval.com | PowerPoint PPT presentation | free to view

Secondary Progressive Multiple Sclerosis Drug Market size PowerPoint PPT Presentation

Secondary Progressive Multiple Sclerosis Drug Market size - : This report studies Secondary Progressive Multiple Sclerosis Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. | PowerPoint PPT presentation | free to view

Antibody peptides PowerPoint PPT Presentation

Antibody peptides - Antibody-peptide Antibody peptides also have high affinity with unlimited access to almost all niches of cells, meanwhile they are easier to manufacture. Antibody-peptide conjugates combine the advantages of mAbs and small molecules. https://www.creative-biolabs.com/bsab/antibody-peptide-conjugates-generation-service.htm | PowerPoint PPT presentation | free to view

Multiple Sclerosis Drugs Market to Exhibit 6.7% CAGR, Leading Companies Focus on Strategic Collaborations to Expand their Footprint PowerPoint PPT Presentation

Multiple Sclerosis Drugs Market to Exhibit 6.7% CAGR, Leading Companies Focus on Strategic Collaborations to Expand their Footprint - Multiple Sclerosis Drugs Market Summarized details by key players are Biogen, Pfizer, Inc., Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd. and Other players | PowerPoint PPT presentation | free to view

Multiple Sclerosis Drugs Market Analysis and Forecast Report 2023 PowerPoint PPT Presentation

Multiple Sclerosis Drugs Market Analysis and Forecast Report 2023 - The global multiple sclerosis drugs market was worth $20.83 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 5.20% and reach $25.52 billion by 2023. Read More @ https://www.thebusinessresearchcompany.com/report/multiple-sclerosis-drugs-market-global-report-2020-covid-19-implications-and-growth | PowerPoint PPT presentation | free to view

Global Peptide Synthesis Market Size, Status and Forecast 2020-2026 PowerPoint PPT Presentation

Global Peptide Synthesis Market Size, Status and Forecast 2020-2026 - Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. | PowerPoint PPT presentation | free to view

COVID-19 Impact on Multiple Sclerosis Drugs Market, Global Research Reports 2020-2021 PowerPoint PPT Presentation

COVID-19 Impact on Multiple Sclerosis Drugs Market, Global Research Reports 2020-2021 - This report covers market size and forecasts of Multiple Sclerosis Drugs, including the following market information: Global Multiple Sclerosis Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global Multiple Sclerosis Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global Multiple Sclerosis Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global Multiple Sclerosis Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units) | PowerPoint PPT presentation | free to view

Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2020-2026 PowerPoint PPT Presentation

Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2020-2026 - Peptide Based Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. | PowerPoint PPT presentation | free to view

Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2020-2026 PowerPoint PPT Presentation

Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2020-2026 - Multiple Sclerosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. | PowerPoint PPT presentation | free to view

Multiple Sclerosis Treatment Market – Future Scope, Industry Trends and Forecast to 2026 PowerPoint PPT Presentation

Multiple Sclerosis Treatment Market – Future Scope, Industry Trends and Forecast to 2026 - Multiple sclerosis treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 24.05 billion by 2027 growing with the CAGR of 0.75% in the above-mentioned forecast period. The launch of effective oral formulations with less oral dosing will help in driving the growth of the multiple sclerosis treatment market. | PowerPoint PPT presentation | free to view

(2021-2030) Multiple Sclerosis Drugs Market Size, Share, Growth And Trends PowerPoint PPT Presentation

(2021-2030) Multiple Sclerosis Drugs Market Size, Share, Growth And Trends - The major players in the multiple sclerosis drugs market are Biogen, Novartis, Roche, Bayer HealthCare, Pfizer Inc., Merck & Co. Inc., Sanofi, Teva Pharmaceutical Industries.... @ @ https://bit.ly/3m8VTS8 | PowerPoint PPT presentation | free to view

Amyotrophic Lateral Sclerosis (ALS) Market - Industry Insights, Drivers, Top Trends, Global Analysis And Forecast to 2027 PowerPoint PPT Presentation

Amyotrophic Lateral Sclerosis (ALS) Market - Industry Insights, Drivers, Top Trends, Global Analysis And Forecast to 2027 - The global Amyotrophic Lateral Sclerosis (ALS) market is majorly driven by the high prevalence of Amyotrophic Lateral Sclerosis (ALS) globally and emergence of drugs treating complication associated with Amyotrophic Lateral Sclerosis (ALS) diseases. In addition, increases in strategic alliances such as geographical alliances and granting the designation such as orphan drug designation is some of the impacting factors that drives the market growth. Nevertheless, insufficient trained expertise or technically skilled professionals coupled with high treatment cost significantly hinder the growth of this market. | PowerPoint PPT presentation | free to view

Multiple Sclerosis Treatment Market - Industry Insights, Drivers, Top Trends, Global Analysis And Forecast to 2027 PowerPoint PPT Presentation

Multiple Sclerosis Treatment Market - Industry Insights, Drivers, Top Trends, Global Analysis And Forecast to 2027 - Multiple sclerosis is a chronic, inflammatory, autoimmune disorder that affects the (CNS) central nervous system, especially the communication between the brain and other areas of the body. Multiple sclerosis (MS) in particular is a demyelinating disease that damages the insulating covers of nerve cells in the brain and spinal cord. There is usually no cure for MS, general care is based on speedy recovery from damage that delays disease progression and manages MS symptoms. | PowerPoint PPT presentation | free to view

Is Stem Cell Therapy Effective Against Multiple Sclerosis? PowerPoint PPT Presentation

Is Stem Cell Therapy Effective Against Multiple Sclerosis? - Umbilical cord blood stem cells helps in curing diseases such as multiple sclerosis. Visit this link to know about the benefits of stem cell banking https://www.cordlifeindia.com/about-stem-cells | PowerPoint PPT presentation | free to view

Amyotrophic Lateral Sclerosis (ALS) Market COVID-19 Impact and Recovery Analysis till 2027 PowerPoint PPT Presentation

Amyotrophic Lateral Sclerosis (ALS) Market COVID-19 Impact and Recovery Analysis till 2027 - Amyotrophic Lateral Sclerosis (ALS) is also known as Lou Gehrig's disease is a rare and progressive neurological condition belongs to the heterogenous group of motor neurons disorders that affects mainly the motor neurons which controls the voluntary muscles. | PowerPoint PPT presentation | free to view

Multiple Sclerosis Treatment Market is anticipated to Increase at a Stable CAGR over the Forecast Period with COVID-19 Study PowerPoint PPT Presentation

Multiple Sclerosis Treatment Market is anticipated to Increase at a Stable CAGR over the Forecast Period with COVID-19 Study - Multiple sclerosis is a chronic, inflammatory, autoimmune disorder that affects the (CNS) central nervous system, especially the communication between the brain and other areas of the body. Multiple sclerosis (MS) in particular is a demyelinating disease that damages the insulating covers of nerve cells in the brain and spinal cord. There is usually no cure for MS, general care is based on speedy recovery from damage that delays disease progression and manages MS symptoms. | PowerPoint PPT presentation | free to view

Multiple Sclerosis Drugs Market Overview and Forecasts through 2030 PowerPoint PPT Presentation

Multiple Sclerosis Drugs Market Overview and Forecasts through 2030 - The global multiple sclerosis drugs market is expected to grow from $21.27 billion in 2020 to $22.04 billion in 2021 at a compound annual growth rate (CAGR) of 3.6%. | PowerPoint PPT presentation | free to view

Multiple Sclerosis Physiotherapy Lalor Park PowerPoint PPT Presentation

Multiple Sclerosis Physiotherapy Lalor Park - At Vuno Physiotherapy and Rehabilitation we offer multiple sclerosis physiotherapy and Disability physiotherapy in Lalor Park for a range of conditions. Our team are highly skilled. https://www.vunophysio.com.au/ndis-and-disability-services/ | PowerPoint PPT presentation | free to view

Multiple Sclerosis Treatment Market key players Insight and Growth Driver Analysis 2027 PowerPoint PPT Presentation

Multiple Sclerosis Treatment Market key players Insight and Growth Driver Analysis 2027 - Global multiple sclerosis treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.5% in the forecast period of 2020 to 2027 | PowerPoint PPT presentation | free to view

Global Multiple Sclerosis Drugs Market Insights, Trends Sales, Supply, Demand 2022-2031 PowerPoint PPT Presentation

Global Multiple Sclerosis Drugs Market Insights, Trends Sales, Supply, Demand 2022-2031 - The global multiple sclerosis drugs market size is expected to grow from $24.75 billion in 2021 to $26.29 billion in 2022 at a compound annual growth rate (CAGR) of 6.2%. | PowerPoint PPT presentation | free to view

Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027 PowerPoint PPT Presentation

Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027 - The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027. | PowerPoint PPT presentation | free to view

Multiple Sclerosis Therapeutics Market Overview, Business Opportunities future, growth 2027 PowerPoint PPT Presentation

Multiple Sclerosis Therapeutics Market Overview, Business Opportunities future, growth 2027 - The Multiple Sclerosis Therapeutics Market was valued at US$ 24,026.90 million in 2019 and it is projected to reach US$ 39,223.59 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027. | PowerPoint PPT presentation | free to view